長期COVIDの臨床的に関連するサブグループにおける統合されたマルチオミクスの特徴づけ
Jingwen Ai1,2, Jingxin Guo1,2, Ke Lin1
1Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China.
National science review
|August 22, 2025
まとめ
ロング・COVID,またはCOVID-19の急性後遺症は,患者のサブグループで異なるマルチオミックシグネチャーを示しています. これらの多様なPASCプロフィールを理解することは,標的型診断と治療戦略の開発の鍵です.
科学分野:
- 免疫学
- ゲノミクス
- メタボロミクス
- プロテオミクス
背景:
- 長期COVIDとして知られるCOVID-19の急性後遺症 (PASC) は,SARS-CoV-2感染後に多くの患者に影響を及ぼします.
- 長期的なCOVID症状と根本的なメカニズムの異質性は,診断と治療に課題をもたらす.
研究 の 目的:
- 異なる長いCOVIDサブグループの異なる病理生理学的メカニズムとマルチオミックシグネチャーを調査する.
- 長期COVIDの異質性を診断し理解するための潜在的なバイオマーカーを特定する.
主な方法:
- トランスクリプトミクス,プロテオミクス,メタボロミクスを含む統合的なマルチオミクス分析.
- 多系統性,神経性,心臓脳性,筋骨格性+全身性,心肺性など,さまざまな長期COVIDサブグループに対する異なる分子プロファイルの特徴付け.
- 長期COVIDおよびそのサブグループに関連した一般的なおよび血清特有のタンパク質バイオマーカーの特定.
主要な成果:
- 長期COVID患者はMAPK経路の活性化が高く,回復した患者では低下しています.
- 特定の代謝とシグナル伝達経路の変化を明らかにする,それぞれの長期COVIDサブグループに対して,異なるマルチオミックシグネチャーが特定されました.
- ABHD17A,CSNK1D,PSME4,SYVN1,CRH,FPGT,CBX6およびRBBP4を含むいくつかの潜在的なバイオマーカーは,一般的およびサブグループ特有の診断のために特定されました.
結論:
- この研究は,PASCの複雑で異質な性質を強調し,共有され,明確な病理学的説明を提供します.
- 特定されたマルチオミックスのシグネチャーとバイオマーカーは,将来の診断ツールと長期のCOVIDに対する標的治療介入の基盤を提供します.
関連する概念動画
Genomics
37.4K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
37.4K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
COPD: Pathogenesis and Clinical Features
517
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
517
Acute Coronary Syndrome III: Diagnostic Studies
23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K


